Carl Hess, MD
Pain Medicine · Fullerton, CANPI 1154471118
Payments from drug & device makers
Across 107 payments — averaging $20.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$382
- Biodelivery Sciences International, Inc.$266
- Medtronic$252
- Boston Scientific$145
- Nevro Corp.$141
- Ziehm-orthoscan, Inc.$128
- plus $848 from 22 others
What the payments were for
- Food & beverage$2,161100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 22 | $382 |
| Biodelivery Sciences International, Inc. | 25 | $266 |
| Medtronic(2 entities) | 6 | $252 |
| Boston Scientific | 1 | $145 |
| Nevro Corp. | 6 | $141 |
| Ziehm-orthoscan, Inc.(2 entities) | 3 | $128 |
| Pfizer | 4 | $90 |
| Arbor Pharmaceuticals, Inc. | 4 | $71 |
| Forte Bio-pharma LLC | 3 | $65 |
| Scilex Pharmaceuticals Inc. | 3 | $63 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $59 |
| Eisai Inc. | 3 | $52 |
| Redhill Biopharma Inc. | 3 | $50 |
| AstraZeneca | 3 | $43 |
| DJO, LLC | 1 | $43 |
| West Therapeutics Development, LLC | 2 | $41 |
| Merz Pharmaceuticals, LLC | 1 | $37 |
| Almatica Pharma LLC | 2 | $37 |
| Valinor Pharma, LLC | 2 | $30 |
| Assertio Therapeutics, Inc. | 2 | $29 |
| Vertos Medical, Inc. | 1 | $27 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $21 |
| Stimwave Technologies Incorporated | 1 | $20 |
| Avanos Medical | 1 | $18 |
| Zyla Life Sciences, Inc. | 1 | $17 |
| Sentynl Therapeutics, Inc. | 1 | $14 |
| Amgen | 1 | $12 |
| Electronic Waveform Lab, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,161 in reported general payments places this provider in the 50th percentile of 840 pain medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 47 | $65,632 |
| Xtampza ErOxycodone Myristate | 49 | $42,993 |
| MovantikNaloxegol Oxalate | 35 | $20,359 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 355 | $11,864 |
| Fentanyl | 50 | $6,056 |
| Morphine Sulfate ErMorphine Sulfate | 132 | $4,317 |
| Oxycodone Hcl | 131 | $3,634 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 135 | $3,068 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 11 | $2,819 |
| Morphine Sulfate | 50 | $2,077 |
| Gabapentin | 156 | $1,622 |
| Celecoxib | 27 | $1,273 |
| Hydromorphone Hcl | 54 | $1,268 |
| Duloxetine Hcl | 65 | $1,225 |
| Tizanidine Hcl | 65 | $1,047 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $382 | $42,99349 claims |
| Redhill Biopharma Inc.Movantik | $50 | $20,35935 claims |
| Almatica Pharma LLCSertraline Hcl | $37 | $8513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 840 pain medicine providers in California.
Other pain medicine in Fullerton
- Shveta JainFullerton$351K
- Eric GrigsbyNapa$3.2M
- Jason PopeSanta Rosa$2.8M
- Javid GhandehariSanta Monica$2.7M
- Alexander HerselThousand Oaks$2.1M
- Krishnan ChakravarthyTemecula$1.9M
- Kasra AmirdelfanWalnut Creek$1.7M
- Ramana NaiduLarkspur$1.6M
- Foead GeulaStudio City$1.3M
- Xiang QianRedwood City$941K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.